Loading…
Mangalam Drugs and Organics (MANGALAM)₹29.22−1.72%Pharmaceuticals
Mangalam Drugs and Organics is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a ROCE of −14.0% against a peer median of −4.0%, and latest-quarter sales growth of −0.2% against a peer median of −20.4%. By market cap it is #5 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phaarmasia | 54 | 3.1 | 15.9 | 12.9 | 0.05 | 0.0 | 47 | 18 | 42.3 | — | vs MANGALAM |
| Biofil Chemicals & Pharmaceuticals | 50 | 18.3 | 15.8 | 13.8 | 0.14 | 0.0 | 28 | 3 | −9.2 | 5.3 | vs MANGALAM |
| Parmax Pharma | 49 | — | −82.9 | — | — | 0.0 | 12 | −4 | −31.5 | — | vs MANGALAM |
| ANG Lifesciences India | 48 | — | −4.0 | −18.9 | 1.50 | 0.0 | 93 | −11 | −37.8 | — | vs MANGALAM |
| Mangalam Drugs and Organics | 46 | — | −14.0 | −35.1 | 1.02 | 0.0 | 232 | −44 | −0.2 | — | — |
| Vivimed Labs | 45 | — | −65.0 | — | — | 0.0 | 70 | −176 | −53.8 | — | vs MANGALAM |
| Vasundhara Rasayans | 44 | 7.4 | 20.2 | 15.2 | 0.04 | 1.5 | 36 | 6 | 53.1 | 441.3 | vs MANGALAM |
| Chandra Bhagat Pharma | 43 | 14.3 | 12.1 | 9.6 | 0.50 | 0.0 | 116 | 3 | 313.6 | — | vs MANGALAM |
| Kabra Drugs | 42 | 8.4 | 20.8 | 18.3 | 0.02 | 0.0 | 93 | 5 | — | 167.5 | vs MANGALAM |
| Vista Pharmaceuticals | 41 | — | −30.0 | −29.5 | 0.27 | 0.0 | 5 | −12 | −100.0 | — | vs MANGALAM |
| Bharat Immunological & Biological Corporation | 38 | — | −8.9 | −17.7 | 0.94 | 0.0 | 45 | −17 | −100.0 | — | vs MANGALAM |
| Peer median | 45 | 8.4 | −4.0 | 9.6 | 0.27 | 0.0 | 47 | −4 | −20.4 | 167.5 |
Listed companies closest to Mangalam Drugs and Organics in Pharmaceuticals include Phaarmasia, Biofil Chemicals & Pharmaceuticals, Parmax Pharma, ANG Lifesciences India, Vivimed Labs, Vasundhara Rasayans, Chandra Bhagat Pharma, Kabra Drugs.
Phaarmasia, with a market cap of ₹54.09 Cr.
Mangalam Drugs and Organics' return on capital employed is −14.0%, below the peer median of −4.0%.